Skip to main content

Public-Private coalition to support COvid-19 affected people

With the endorsement of the Office of the Mayor, a new public-private sector coalition is preparing to support 1.2 million people affected by the ongoing COVID-19 pandemic in the capital. The effort, worth USD 6 million, is to be providing scarce resources such as water, soap, water tankers, as well as development of behavioural change education within the densest areas of Addis Ababa.

  COVID-19 crisis creates uptick in condom sales  

In light of businesses shutting down and people staying at home, amid the pandemic, the economic and social sectors of Ethiopia are enduring a heavy cost. However, the pandemic has offered an uptick in the condom market with a surge in the consumption level in Addis Ababa, a report shows.

Government receives support from Japan, Novartis

With the growing number of confirmed cases and the full impact of the pandemic on the economy yet to be seen, the government of Ethiopia has received grants and financial backings, the latest coming from the government of Japan and the Swiss multinational medicine company, Novartis.

Authority downplays poisoned water rumor

The Addis Ababa Water and Sewage Authority is downplaying rumors that spread in the capital over accusations that one of the city’s main sources of water is poisoned and is no longer fit for human consumption.

Lycée accepts parents’ decry over hiked fees

Lycée Guébré-Mariam, a French community school, has been facing angry parents over its recent school fee price hike, until the school came up with certain adjustments that will impose a 20 percent added fee on those parents who can afford it, The Reporter has learnt.

Virtual job expo come to Addis

Ethiopia’s first online career expo is coming to the capital. A partnership of, a subsidiary of Mind Solutions PLC, and Mastercard Foundation and the Jobs Creation Commission of Ethiopia (JCC), it is to replace the one held in the capital and in person, now forced to go virtual in the midst of COVID-19.